• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

H&Q Life Sciences Investors

+ Add to Watchlist

XHQLX:US

23.37 USD 0.13 0.55%

As of 09:29:30 ET on 09/30/2014.

Snapshot for H&Q Life Sciences Investors (XHQLX)

Year To Date: +20.82% 3-Month: +6.87% 3-Year: +38.98% 52-Week Range: 18.26 - 23.99
1-Month: +0.30% 1-Year: +29.17% 5-Year: +25.26% Beta vs NBI: 0.86

Mutual Fund Chart for XHQLX

No chart data available.
  • XHQLX:US 23.37
  • 1M
  • 1Y
Interactive XHQLX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XHQLX

H&Q Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth.

Inception Date: 05-08-1992 Telephone: 1-617-772-8500
Managers: DANIEL R OMSTEAD
Web Site: www.teklacap.com

Fundamentals for XHQLX

NAV (on 2014-09-30) 23.37
Assets (M) (on 2014-09-30) 444.09
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for XHQLX

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-08-27) 0.45
Dividend Yield (ttm) 7.10

Fees & Expenses for XHQLX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.05
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 1.47

Top Fund Holdings for XHQLX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 464,770 34,927,466 10.909%
Celgene Corp 313,910 26,519,117 8.282%
Regeneron Pharmaceuticals Inc 81,959 22,558,395 7.045%
Biogen Idec Inc 59,788 16,725,693 5.224%
Alexion Pharmaceuticals Inc 111,924 14,892,607 4.651%
Amgen Inc 125,374 14,312,696 4.470%
Incyte Corp 227,088 11,497,466 3.591%
Vertex Pharmaceuticals Inc 153,029 11,370,055 3.551%
Perrigo Co PLC 66,228 10,163,349 3.174%
iShares Nasdaq Biotechnology E 38,280 8,691,857 2.715%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil